Andrew Meunier

Principal
404-645-7711
dmeunier@m2IPlaw.com

Mr. Meunier specializes in preparing and prosecuting domestic and international patent applications and preparing non-infringement and invalidity opinions for clients in the chemical, pharmaceutical and medical device industries.  Mr. Meunier also has extensive experience in reexamination and reissue practice.

Mr. Meunier has experience in various technological areas including polymers, pesticides, pharmaceuticals, cosmetics, nonwovens, medical devices, paints and coatings, biofuels, electrochemistry, nanoparticles, inks, fly ash chemistry, drug delivery systems, genetically modified crops, adhesives, bone grafting materials, lithium battery active materials, asphalt formulations, pulp and paper chemistry, orthopedic braces, coaxial cables, and fiber optics.
Mr. Meunier has lectured on various topics of intellectual property law including post-grant amendment of patent claims, foreign filing strategies and prosecution, trade secrets, patent searching strategies, and maintaining inventorship records.

Memberships and Affiliations
Executive Committee, U.S. Group, Association Internationale pour la Protection de la Propriété Intellectuelle (AIPPI)
Member, Fédération Internationale des Conseils en Propriété Industrielle (FICPI),
Member, AIPLA Chemical Practice and International and Foreign Law Committees
Member, North Carolina and Georgia Bar IP sections.

Publications and Presentations
Co-author of: "The Metal Oxide Nanoparticle Patent Landscape," Rishi Gupta, Kimberlynn Davis, Christopher Ramsey, Andrew Meunier, and Kelly Kordzik, 6 Nanotechnology Law & Business (Issue 3, 2009).

Co-Author of: "Royalty Rate Trends and Valuation in Patent and Technology Licensing," Aspen Law & Business Journal, co-authored the Journal's Licensing Update annually from 2000-2007.

Presentor: “Maximizing IP Value in an Economic Downturn.”; Fish & Richardson Munich Seminar, 2009.

Presentor: “When is an Invention “Obvious”? Practical Implications for Dealing with Shifting Legal Standards.”; Fish & Richardson Munich Seminar, 2008.

Presented at the 2005 and 2006 AIPPI U.S. Annual Meetings on Working Question Q189 - Post-Grant Amendment of Patent Claims. 

Prior Experience
Principal, Fish & Richardson P.C.
Partner, Head of Chemical and Pharmaceutical Patents Group, Alston & Bird LLP

Services

Patent Prosecution
Opinions (Freedom to Operate, Noninfringement, and Validity)
Reexamination
Reissue
Portfolio Analysis
Licensing
Transactional Due Diligence
Pre-Litigation Counseling
General IP Counseling

Technologies

Chemistry
Pharmaceuticals
Medical Devices
Mechanical/Electrical
Biotechnology

Admissions

Georgia
North Carolina
United States Patent and Trademark Office

Education

BS, Georgia Institute of Technology
Chemical Engineering, with highest honors

JD, University of North Carolina at Chapel Hill